Bloomberg News

Top Canada Court Denies Pfizer Appeal over Apotex Glaucoma Drug

February 02, 2012

Feb. 2 (Bloomberg) -- The Supreme Court of Canada today denied an appeal by Pfizer Canada Inc. over a generic drug produced by Apotex Inc. to treat glaucoma.

Pfizer appealed to the Supreme Court after a lower court overturned an earlier order that had prevented Apotex from marketing a generic version of the drug Xalatan.

To contact the reporter on this story: Greg Quinn in Ottawa at

To contact the editor responsible for this story: Paul Badertscher at

We Almost Lost the Nasdaq

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus